Works by Sangroongruangsri, Sermsiri

Results: 17
    1
    2

    Cost-Utility Analysis of Deep Learning and Trained Human Graders for Diabetic Retinopathy Screening in a Nationwide Program.

    Published in:
    Ophthalmology & Therapy, 2023, v. 12, n. 2, p. 1339, doi. 10.1007/s40123-023-00688-y
    By:
    • Srisubat, Attasit;
    • Kittrongsiri, Kankamon;
    • Sangroongruangsri, Sermsiri;
    • Khemvaranan, Chalida;
    • Shreibati, Jacqueline Baras;
    • Ching, Jack;
    • Hernandez, John;
    • Tiwari, Richa;
    • Hersch, Fred;
    • Liu, Yun;
    • Hanutsaha, Prut;
    • Ruamviboonsuk, Varis;
    • Turongkaravee, Saowalak;
    • Raman, Rajiv;
    • Ruamviboonsuk, Paisan
    Publication type:
    Article
    3

    The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study.

    Published in:
    ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 233, doi. 10.2147/CEOR.S504462
    By:
    • Nagi, Mouaddh Abdulmalik;
    • Almalki, Ziyad Saeed;
    • Thavorncharoensap, Montarat;
    • Sangroongruangsri, Sermsiri;
    • Turongkaravee, Saowalak;
    • Chaikledkaew, Usa;
    • Alqahtani, Abdulhadi M;
    • AlSharif, Lamis S;
    • Alsubaihi, Ibrahim A;
    • Alzarea, Abdulaziz I;
    • Alsultan, Mohammed M
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study.

    Published in:
    2019
    By:
    • Sangroongruangsri, Sermsiri;
    • Chaikledkaew, Usa;
    • Kumluang, Suthasinee;
    • Wu, Olivia;
    • Geue, Claudia;
    • Ratanapakorn, Tanapat;
    • Leelahavarong, Pattara;
    • Ingsrisawang, Lily;
    • Ruamviboonsuk, Paisan;
    • Taweebanjongsin, Wongsiri;
    • Choovuthayakorn, Janejit;
    • Singalavanija, Apichart;
    • Hanutsaha, Prut;
    • Kulvichit, Kittisak;
    • Ratanapojnard, Thitiporn;
    • Wongsawad, Warapat;
    • Teerawattananon, Yot
    Publication type:
    Correction Notice
    13

    Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study.

    Published in:
    Clinical Drug Investigation, 2018, v. 38, n. 9, p. 853, doi. 10.1007/s40261-018-0678-5
    By:
    • Sangroongruangsri, Sermsiri;
    • Chaikledkaew, Usa;
    • Kumluang, Suthasinee;
    • Wu, Olivia;
    • Geue, Claudia;
    • Ratanapakorn, Tanapat;
    • Leelahavarong, Pattara;
    • Ingsrisawang, Lily;
    • Ruamviboonsuk, Paisan;
    • Taweebanjongsin, Wongsiri;
    • Choovuthayakorn, Janejit;
    • Singalavanija, Apichart;
    • Hanutsaha, Prut;
    • Kulvichit, Kittisak;
    • Ratanapojnard, Thitiporn;
    • Wongsawad, Warapat;
    • Teerawattananon, Yot
    Publication type:
    Article
    14
    15
    16

    A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand.

    Published in:
    2019
    By:
    • Kumluang, Suthasinee;
    • Ingsrisawang, Lily;
    • Sangroongruangsri, Sermsiri;
    • Chaikledkaew, Usa;
    • Ratanapakorn, Tanapat;
    • Ruamviboonsuk, Paisan;
    • Taweebanjongsin, Wongsiri;
    • Choovuthayakorn, Janejit;
    • Thoongsuwan, Somanus;
    • Hanutsaha, Prut;
    • Kulvichit, Kittisak;
    • Ratanapojnard, Thitiporn;
    • Wongsawad, Warapat;
    • Leelahavarong, Pattara;
    • Teerawattananon, Yot
    Publication type:
    journal article
    17